These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8279352)

  • 1. Maximizing benefits of therapies in acute myocardial infarction.
    Le Feuvre C; Yusuf S; Flather M; Farkouh M
    Am J Cardiol; 1993 Dec; 72(19):145G-155G. PubMed ID: 8279352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to use ACE-inhibitors, beta-blockers, and newer therapies in AMI.
    Maggioni AP; Latini R
    Am Heart J; 1999 Aug; 138(2 Pt 2):S183-7. PubMed ID: 10426880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy for acute myocardial infarction.
    Rich MW
    Clin Geriatr Med; 1996 Feb; 12(1):141-68. PubMed ID: 8653655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for acute myocardial infarction. Overview of randomized clinical trials.
    Yusuf S; Anand S; Avezum A; Flather M; Coutinho M
    Eur Heart J; 1996 Dec; 17 Suppl F():16-29. PubMed ID: 8960444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.
    Yusuf S; Sleight P; Held P; McMahon S
    Circulation; 1990 Sep; 82(3 Suppl):II117-34. PubMed ID: 1975522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic management of angina and acute myocardial infarction.
    Rutherford JD
    Am J Cardiol; 1993 Sep; 72(8):16C-19C; discussion 19C-20C. PubMed ID: 8372796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibitors in heart failure: what more do we need to know?
    Demers C; Mody A; Teo KK; McKelvie RS
    Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Integration of therapeutic options and the candidates for treatment: the ABC of the post-infarction period].
    Ambrosioni E; Bacchelli S; Borghi C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():132S-138S. PubMed ID: 9004813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of therapeutic interventions in myocardial infarction. Emphasis on secondary prevention.
    Hinstridge V; Speight TM
    Drugs; 1991; 42 Suppl 2():8-20. PubMed ID: 1718703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management after myocardial infarction: an evidence-based perspective.
    Sharpe N
    Br J Clin Pract Suppl; 1996 Jul; 84():25-30. PubMed ID: 8994999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients after myocardial infarction and thrombolytic therapy.
    O'Rourke RA
    Curr Probl Cardiol; 1994 Apr; 19(4):179-226. PubMed ID: 8205834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reperfusion adjunctive therapy.
    Cairns JA
    Chest; 1991 Apr; 99(4 Suppl):141S-149S. PubMed ID: 2009811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive pharmacologic therapy for acute myocardial infarction.
    Pepine CJ
    Clin Cardiol; 1994 Jan; 17(1 Suppl 1):I10-4. PubMed ID: 7908862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.
    Goa KL; Balfour JA; Zuanetti G
    Drugs; 1996 Oct; 52(4):564-88. PubMed ID: 8891468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.
    Bangalore S; Makani H; Radford M; Thakur K; Toklu B; Katz SD; DiNicolantonio JJ; Devereaux PJ; Alexander KP; Wetterslev J; Messerli FH
    Am J Med; 2014 Oct; 127(10):939-53. PubMed ID: 24927909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.